CIK 0001479681
- Accelerated filer
Nutex Health Inc.
Sign in to watch- Ticker
- NUTX
- Exchange
- Nasdaq
- Industry
- Services-Business Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113363609
- Phone
- +1 713-660-0557
- Business address
- 1776 YORKTOWN ST, SUITE 700, HOUSTON, TX, 77056
- Former names
- Nutex Health, Inc., Clinigence Holdings, Inc., iGambit, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,493
- in 1 filing
Net −$43,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-27 | Creem Mitchell Director | Grant or award · Director Stock Option (right to buy) | +45,000 | 55,120 | ||
| 2020-01-27 | Hosseinion Warren Director | Grant or award · Director Stock Option (right to buy) | +100,000 | 121,590 | ||
| 2020-01-27 | Hosseinion Warren Director | Purchase · Director Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2020-01-27 | Waters John J Director | Grant or award · Director Stock Option (right to buy) | +45,000 | 119,031 | ||
| 2020-01-27 | Schimmel Lawrence Chief Medical Officer | Grant or award · Officer Stock Option (right to buy) | +6,288 | 6,288 | ||
| 2020-01-27 | Breslin Terence Martin Director | Grant or award · Director Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2020-01-27 | Meiri David Director | Grant or award · Director Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2020-01-27 | Luqman Elisa V Chief Financial Officer | Grant or award · Officer Stock Option (right to buy) | +61,706 | 61,706 | ||
| 2020-01-27 | Luqman Elisa V Chief Financial Officer | Grant or award · Officer Stock Option (right to buy) | +5,400 | 5,400 | ||
| 2020-01-27 | Waters John J Director | Grant or award · Director Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2020-01-27 | Waters John J Director | Grant or award · Director Stock Option (right to buy) | +7,800 | 7,800 | ||
| 2019-11-19 | Waters John J Director | Purchase · Convertible Promissory Note | +1 | $100,000.00 | $100K | 60,236 |
| 2019-11-19 | Waters John J Director | Purchase · Warrant | +50,000 | 110,236 | ||
| 2019-11-15 | Waters John J Director | Other disposition · Convertible Debenture | −1 | $25,000.00 | $25K | 0 |
| 2019-11-15 | Waters John J Director | Other disposition · Warrant | −50,000 | 0 | ||
| 2019-11-15 | Waters John J Director | Purchase · Convertible Debenture | +1 | $32,500.00 | $33K | 26,000 |
| 2019-11-15 | Waters John J Director | Purchase · Warrant | +16,250 | 42,250 | ||
| 2019-03-21 | Fawcett Mark Director | Purchase · Warrants to Puchase common stock | +3,598 | $6.67 | $24K | 3,598 |
| 2019-03-19 | Hosseinion Warren Chief Executive Officer | Purchase · Warrants to Puchase common stock | +21,590 | $6.67 | $144K | 21,590 |
| 2014-06-30 | Salerno John CEO & President | Gift | −400,000 | 5,070,000 |
Page 11 of 12 · 225 trades